마로니에 (말밤)

Modulation of Wnt/β-Catenin Pathway by Aesculus hippocastanum Extract Enhances Temozolomide Sensitivity in Glioblastoma Cells.

1. J Cell Mol Med. 2026 Feb;30(4):e70979. doi: 10.1111/jcmm.70979. Modulation of Wnt/β-Catenin Pathway by Aesculus hippocastanum Extract Enhances Temozolomide Sensitivity in Glioblastoma Cells. Scuderi SA(1), Ardizzone A(2), Mannino D(3), Palermo N(4), De Luca F(5), Catalfamo A(5), Campolo M(5),

Drug interactions of natural supplements in dermatology: a review.

2. Int J Dermatol. 2021 Oct;60(10):1183-1189. doi: 10.1111/ijd.15389. Epub 2020 Dec 23. Drug interactions of natural supplements in dermatology: a review. Hadeler EK(1), Maderal AD(1). Author information: (1)Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami,

β-Aescin at subinhibitory concentration (sub-MIC) enhances susceptibility of Candida glabrata clinical isolates to nystatin.

3. Med Mycol. 2015 Nov;53(8):845-51. doi: 10.1093/mmy/myv035. Epub 2015 Jun 19. β-Aescin at subinhibitory concentration (sub-MIC) enhances susceptibility of Candida glabrata clinical isolates to nystatin. Franiczek R(1), Gleńsk M(2), Krzyżanowska B(3), Włodarczyk M(2). Author information: (1)Dep

The influence of herbal medicine on platelet function and coagulation: a narrative review.

4. Semin Thromb Hemost. 2015 Apr;41(3):300-14. doi: 10.1055/s-0035-1549089. Epub 2015 Apr 3. The influence of herbal medicine on platelet function and coagulation: a narrative review. McEwen BJ(1). Author information: (1)Department of Naturopathic Medicine, Endeavour College of Natural Health,

Effects of aescin on cytochrome P450 enzymes in rats.

5. J Ethnopharmacol. 2014;151(1):583-90. doi: 10.1016/j.jep.2013.11.016. Epub 2013 Nov 16. Effects of aescin on cytochrome P450 enzymes in rats. Huang Y(1), Zheng SL(2), Zhu HY(3), Xu ZS(4), Xu RA(5). Author information: (1)Wenzhou People's Hospital, Wenzhou 325000, China. (2)The Second Affiliat

Synergistic protective effects of escin and low‑dose glucocorticoids on blood‑retinal barrier breakdown in a rat model of retinal ischemia.

6. Mol Med Rep. 2013 May;7(5):1511-5. doi: 10.3892/mmr.2013.1374. Epub 2013 Mar 15. Synergistic protective effects of escin and low‑dose glucocorticoids on blood‑retinal barrier breakdown in a rat model of retinal ischemia. Zhang F(1), Li Y, Zhang L, Mu G. Author information: (1)Department of Op

Escin exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vivo and in vitro.

7. Phytomedicine. 2011 Feb 15;18(4):272-7. doi: 10.1016/j.phymed.2010.08.013. Epub 2010 Sep 18. Escin exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vivo and in vitro. Xin W(1), Zhang L, Sun F, Jiang N, Fan H, Wang T, Li Z, He J, Fu F. Author information: (1)D

Trade herbal products and induction of CYP2C19 and CYP2E1 in cultured human hepatocytes.

8. Basic Clin Pharmacol Toxicol. 2009 Jul;105(1):58-63. doi: 10.1111/j.1742-7843.2009.00412.x. Epub 2009 Apr 3. Trade herbal products and induction of CYP2C19 and CYP2E1 in cultured human hepatocytes. Hellum BH(1), Hu Z, Nilsen OG. Author information: (1)Department of Cancer Research and Molecu

[Horse chestnut--remedy for chronic venous insufficiency].

9. Tidsskr Nor Laegeforen. 2009 Feb 26;129(5):420-2. doi: 10.4045/tidsskr.09.33871. [Horse chestnut--remedy for chronic venous insufficiency]. [Article in Norwegian] Methlie CB(1), Schjøtt J. Author information: (1)camilla.borthen@helse-bergen.no Horse- chestnut seed extract is widely used thro

In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products.

10. Basic Clin Pharmacol Toxicol. 2008 May;102(5):466-75. doi: 10.1111/j.1742-7843.2008.00227.x. Epub 2008 Mar 6. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Hellum BH(1), Nilsen OG. Author information: (1)Department of Cancer Researc

Systematic literature review and network Meta-analysis of sulodexide and other drugs in chronic venous disease.

11. Phlebology. 2021 Oct;36(9):695-709. doi: 10.1177/02683555211015020. Epub 2021 May 13. Systematic literature review and network Meta-analysis of sulodexide and other drugs in chronic venous disease. Pompilio G(1), Nicolaides A(2)(3), Kakkos SK(4), Integlia D(1). Author information: (1)Isheo

Rutosides for treatment of post-thrombotic syndrome.

12. Cochrane Database Syst Rev. 2018 Nov 8;11(11):CD005625. doi: 10.1002/14651858.CD005625.pub4. Rutosides for treatment of post-thrombotic syndrome. Morling JR(1), Broderick C, Yeoh SE, Kolbach DN. Author information: (1)Division of Epidemiology and Public Health, University of Nottingham, C120

Rutosides for prevention of post-thrombotic syndrome.

13. Cochrane Database Syst Rev. 2018 Nov 8;11(11):CD005626. doi: 10.1002/14651858.CD005626.pub4. Rutosides for prevention of post-thrombotic syndrome. Morling JR(1), Yeoh SE, Kolbach DN. Author information: (1)Division of Epidemiology and Public Health, University of Nottingham, C120, Clinical

Rutosides for treatment of post-thrombotic syndrome.

14. Cochrane Database Syst Rev. 2015 Sep 16;(9):CD005625. doi: 10.1002/14651858.CD005625.pub3. Rutosides for treatment of post-thrombotic syndrome. Morling JR(1), Yeoh SE, Kolbach DN. Author information: (1)Centre for Population Health Sciences, University of Edinburgh, Medical Buildings, Tevio

Rutosides for prevention of post-thrombotic syndrome.

15. Cochrane Database Syst Rev. 2015 Sep 16;(9):CD005626. doi: 10.1002/14651858.CD005626.pub3. Rutosides for prevention of post-thrombotic syndrome. Morling JR(1), Yeoh SE, Kolbach DN. Author information: (1)Centre for Population Health Sciences, University of Edinburgh, Medical Buildings, Tevi

A Systematic Review of the Efficacy of Bioactive Compounds in Cardiovascular Disease: Carbohydrates, Active Lipids and Nitrogen Compounds.

40. Ann Nutr Metab. 2015;66(2-3):168-181. doi: 10.1159/000430960. Epub 2015 May 30. A Systematic Review of the Efficacy of Bioactive Compounds in Cardiovascular Disease: Carbohydrates, Active Lipids and Nitrogen Compounds. Pastor-Villaescusa B, Rangel-Huerta OD, Aguilera CM, Gil A. BACKGROUND/AI

Rutosides for prevention of post-thrombotic syndrome.

16. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD005626. doi: 10.1002/14651858.CD005626.pub2. Rutosides for prevention of post-thrombotic syndrome. Morling JR(1), Yeoh SE, Kolbach DN. Author information: (1)Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK. Dinanda.

Rutosides for treatment of post-thrombotic syndrome.

44. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD005625. doi: 10.1002/14651858.CD005625.pub2. Rutosides for treatment of post-thrombotic syndrome. Morling JR(1), Yeoh SE, Kolbach DN. Author information: (1)Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK. Update i

Horse chestnut seed extract for chronic venous insufficiency.

1. Cochrane Database Syst Rev. 2012 Nov 14;11(11):CD003230. doi: 10.1002/14651858.CD003230.pub4. Horse chestnut seed extract for chronic venous insufficiency. Pittler MH(1), Ernst E. Author information: (1)German Cochrane Centre, Institute of Medical Biometry and Medical Informatics University

Horse chestnut seed extract for chronic venous insufficiency.

13. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003230. doi: 10.1002/14651858.CD003230.pub3. Horse chestnut seed extract for chronic venous insufficiency. Pittler MH(1), Ernst E. Author information: (1)Peninsula Medical School, Universities of Exeter and Plymouth, Complementary Medicine, 25 V